Use of anti-IL-20 antibody for treating osteoporosis

Details Use of anti-IL-20 antibody for treating osteoporosis Use of anti-IL-20 antibody for treating osteoporosis

2008-10-07

2010-11-23

Jiang, Dong (Department: 1646)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C424S134100, C424S141100, C424S085100

Reexamination Certificate

active

07837994

ABSTRACT:
Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

REFERENCES:
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 7122632 (2006-10-01), Foster et al.
patent: 7435800 (2008-10-01), Chang
patent: 7611705 (2009-11-01), Chang
patent: 2002/0151532 (2002-10-01), Kagan et al.
patent: 2003/0148955 (2003-08-01), Plenneke
patent: 2004/0235728 (2004-11-01), Stoch et al.
patent: 2004/0235808 (2004-11-01), Wang
patent: 2005/0003475 (2005-01-01), Foster et al.
patent: 2005/0136004 (2005-06-01), Xu et al.
patent: 2005/0143333 (2005-06-01), Richards et al.
patent: 2006/0142550 (2006-06-01), Chang
patent: 2006/0177447 (2006-08-01), Xu
patent: 2006/0269551 (2006-11-01), Thompson et al.
Hsu Y.H. et al., “Function of Interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis”, Arthritis and Rheumatism, vol. 54(9), pp. 2722-2733 (Sep. 2006).
Hsieh M.Y. et al., “Interleukin-20 promotes angiogenesis in a direct and indirect manner”, Genes and Immunity, vol. 7(3), pp. 234-242 (Apr. 2006).
Wei C.C. et al., “IL-20: Biological functions and clinical implications”, Journal of Biomedical Science, vol. 13(5), pp. 601-612 (May 16, 2006).
Sabat R. et al., “IL-19 and IL-20: Two novel cytokines with importance in inflammatory diseases”, Expert Opinion on Therapeutic Targets, vol. 11(5), pp. 601-612 (May 2007).
Wei C.C. et al., “Detection of IL-20 and its receptors on psoriatic skin”, Clinical Immunology, vol. 117(1), pp. 65-72 (Oct. 2005).
Chen, W-Y. et al. (2009). “IL-20 is Regulated by Hypoxia-Inducible Factor and Up-Regulated After Experimental Ischemic Stroke,”Journal of Immunology182:5003-5012.
GenBank Accession No. AAK84423.1, last updated Aug. 9, 2001, located at <http://www.ncbi.nlm.nih,gov/protein/15128211>, last visited on Jan. 14, 2010, one page.
Hunt, D.W.C. et al. (Sep./Oct. 2006). “Ultraviolet B Light Stimulates Interleukin-20 Expression by Human Epithelial Keratinocytes,”Photochemistry and Photobiology82:1292-1300.
International Search Report mailed on Dec. 19, 2007, for PCT Application No. PCT/US06/46802, filed on Dec. 7, 2006, five pages.
International Search Report mailed on Feb. 18, 2010, for PCT Application No. PCT/US2009/059872, filed on Oct. 7, 2009, five pages.
International Search Report mailed on Feb. 24, 2010, for PCT Application No. PCT/US09/59865, filed on Oct. 7, 2009, five pages.
Mayo Clinic. (Jul. 8, 2008). “Stroke. Treatment and Drugs” located at <http://www.MayoClinic.com>>, last visited on Sep. 29, 2009, three pages.
Mayo Clinic. (2001-2009). “Stroke,” located at <http://www.MayoClinic.com>, last visited on Sep. 29, 2009, two pages.
Sabat, R. et al. (May 2007). “IL-19 and IL-20: Two Novel Cytokines with Importance in Inflammatory Diseases,”Expert Opinion on Therapeutic Targets11(5):601-612, Abstract Only, two pages.
Written Opinion mailed on Dec. 19, 2007, for PCT Application No. PCT/US06/46802, filed on Dec. 7, 2006, four pages.
Written Opinion mailed on Feb. 18, 2010, for PCT Application No. PCT/US2009/059872, filed on Oct. 7, 2009, six pages.
Written Opinion mailed on Feb. 24, 2010, for PCT Application No. PCT/US09/59865, filed on Oct. 7, 2009, five pages.

Affiliated with

Also associated with

Rating

Use of anti-IL-20 antibody for treating osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of anti-IL-20 antibody for treating osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anti-IL-20 antibody for treating osteoporosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4157298